Myriad Genetics reported $164.9M in Sales Revenues for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Accelerate Diagnostics AXDX:US 2.96M 385K
Agilent A:US $ 1607M 67M
Becton, Dickinson and BDX:US $ 5011M 16M
Bio Rad Laboratories BIO:US $ 700.06M 32.71M
Biocept BIOC:US $ 19.94M 5.97M
Bruker BRKR:US $ 595M 88.5M
Danaher DHR:US $ 7688M 460M
Exact Sciences EXAS:US $ 486.57M 12.76M
Fluidigm FLDM:US $ 26.5M 11.76M
Hologic HOLX:US $ 1435.7M 35.4M
Illumina ILMN:US $ 1223M 24M
Johnson & Johnson JNJ:US $ 23426M 1378M
Mettler Toledo International MTD:US 897.79M 139.45M
Myriad Genetics MYGN:US $ 164.9M 4.1M
Nanostring Technologies NSTG:US $ 31.08M 11.38M
Orasure Technologies OSUR:US $ 67.71M 4.14M
Pacific Biosciences Of California PACB:US $ 33.17M 2.85M
Perkinelmer PKI:US $ 1259.44M 104.88M
Quest Diagnostics DGX:US $ 2611M 133M
Quidel QDEL:US $ 1002.26M 365.39M
Repligen RGEN:US $ 206.4M 19.88M
Thermo Fisher Scientific TMO:US $ 11818M 1116M
Veracyte VCYT:US $ 67.78M 0.45M
Waters WAT:US $ 690.57M 145.88M